- Filed
- Apr 27, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 6.23M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 5.85M sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 5.85M sh |
| Shares Outstanding | FY 2025 · Dec 31, 2025 | 7.02M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$46K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$8M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | −$16.95M |
| Short Term Investments | FY 2025 · Dec 31, 2025 | $217K |
| Short Term Investments | FY 2025 · Dec 31, 2024 | $265K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $2K |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $3.44M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$1.45M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $23.69M |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $41.31M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $4.05M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $1.81M |
| Current Assets | FY 2025 · Dec 31, 2025 | $219K |
| Current Assets | FY 2025 · Dec 31, 2024 | $265K |
| Total Assets | FY 2025 · Dec 31, 2025 | $7.49M |
| Total Assets | FY 2025 · Dec 31, 2024 | $377K |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $0.66 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$4.30 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | −$3.00 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $0.66 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$4.30 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | −$3.00 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $2.37M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $9.46M |
| Sga Expense | FY 2025 · Dec 31, 2023 | $9.55M |
| Net Income | FY 2025 · Dec 31, 2025 | $4.14M |
| Net Income | FY 2025 · Dec 31, 2024 | −$25.15M |
| Net Income | FY 2025 · Dec 31, 2023 | −$17.57M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$2.37M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$9.46M |
| Operating Income | FY 2025 · Dec 31, 2023 | −$19.29M |
| Capex | FY 2025 · Dec 31, 2023 | $83K |
| Rd Expense | FY 2025 · Dec 31, 2023 | $8.31M |